New Drug Therapy for Asthma and Respiratory Disorders

The drug treatment called TSG12 is not toxic in human cells and prevents airway or pulmonary resistance (resistance of the respiratory tract to airflow during inhalation and expiration) when asthma is caused by triggers like eggs and dust mites (egg-and dust mite-induced asthma). Effective treatment in a protein form can help millions of individuals with asthma and other respiratory disorders such as chronic obstructive pulmonary disease (COPD).

Related Links